SciELO - Scientific Electronic Library Online

 
vol.19 número2Gestão de processos, indicadores analíticos e impactos sobre o desempenho competitivo em grandes e médias empresas brasileiras dos setores da indústria e de serviçosA transferência de tecnologia universidade-empresa no contexto brasileiro: uma revisão de estudos científicos publicados entre os anos 2005 e 2009 índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Artigo

Indicadores

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Gestão & Produção

versão impressa ISSN 0104-530X

Resumo

SANTOS, Maria Clara Bottino Gonçalves  e  PINHO, Marcelo. Changing technology strategies: a study of brazilian pharmaceutical industry. Gest. Prod. [online]. 2012, vol.19, n.2, pp. 405-418. ISSN 0104-530X.  http://dx.doi.org/10.1590/S0104-530X2012000200013.

The aim of this research is to analyze the extension of changes in technological strategies of a group of Brazilian pharmaceutical companies, which we believe were induced by transformations in the institutional environment during the 1990s. Major institutional changes, such as the enacting of laws that recognized drug patents rights and fostered generic drugs market, have strengthened the market insertion and competitive position of these companies, what would enable an increase in research and development efforts in Brazil. In addition to the literature on technology strategy and drug industry, this study was based on interviews with six Brazilian pharmaceutical companies, all of which were ranked among the top national companies in the industry and have been considered in previous studies particularly active in the process of changing technological strategies. This research confirmed a significant intensification of technology efforts carried out by Brazilian drug companies. Nevertheless, the R&D intensity is still far below the global pattern and innovative impacts are slight.

Palavras-chave : technology strategy; pharmaceutical industry; brazilian pharmaceutical companies; innovation; drugs patents economic effects; generic drugs economic effects.

        · resumo em Português     · texto em Português     · pdf em Português